Evidence map›Paper›PMID 39513869›Full record

ArticleCells2024

Evaluation of Vincamine Loaded with Silver Nanoparticles as a New Potential Therapeutic Agent Against Ehrlich's Solid Carcinoma in Mice.

Naief Dahran, Mohamed S Othman, Mohamed E Ghoniem, Mai A Samak, Mohamed T Elabbasy, Sofian T Obeidat, Ghada M Aleid, Shimaa Abo Elnaga, Azza M Khaled, Aya A Altaleb and 1 more

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Naief DahranDepartment of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah 21959, Saudi Arabia.ORCID 0000-0003-3560-8166
Mohamed S OthmanBiochemistry Department, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0002-0316-0961
Mohamed E GhoniemDepartment of Internal Medicine, College of Medicine, University of Ha'il, Ha'il 2240, Saudi Arabia.ORCID 0000-0002-3957-4365
Mai A SamakCollege of Medicine, University of Ha'il, Ha'il 2240, Saudi Arabia.ORCID 0000-0002-5837-3921
Mohamed T ElabbasyCollege of Medicine, University of Ha'il, Ha'il 2240, Saudi Arabia.ORCID 0000-0002-0138-825X
Sofian T ObeidatBasic Sciences Department, Deanship of Preparatory Year, University of Ha'il, Ha'il 2440, Saudi Arabia.ORCID 0000-0003-3096-9464
Ghada M AleidBiochemistry Department, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Shimaa Abo ElnagaBasic Sciences Department, Deanship of Preparatory Year, University of Ha'il, Ha'il 2440, Saudi Arabia.
Azza M KhaledBiochemistry Department, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
Aya A AltalebCollege of Medicine, University of Gazi, Ankara 06500, Turkey.
Ahmed E Abdel MoneimZoology and Entomology Department, Faculty of Science, Helwan University, Ain Helwan, Cairo 11795, Egypt.ORCID 0000-0002-2654-2591

Funding

Scientific Research Deanship at University of Ha'il - Saudi Arabia RG-23067
6 · The paper itself

Abstract

Vincamine, a monoterpenoid indole alkaloid with vasodilatory properties, is extracted from the leaves of

Indexed as

Carcinoma, Ehrlich TumorMetal NanoparticlesSilverAnimalsAntineoplastic AgentsAntioxidantsApoptosisLipid PeroxidationMaleMiceNitric OxideOxidative StressAntineoplastic AgentsAntioxidantsNitric OxideSilverangiogenesisanticancerapoptosisEhrlich solid carcinomavincamine

Identifiers

PMID39513869
PMCPMC11545257

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.